242 related articles for article (PubMed ID: 33636222)
1. The effect of variable troponin C mutation thin filament incorporation on cardiac muscle twitch contractions.
Mijailovich SM; Prodanovic M; Poggesi C; Powers JD; Davis J; Geeves MA; Regnier M
J Mol Cell Cardiol; 2021 Jun; 155():112-124. PubMed ID: 33636222
[TBL] [Abstract][Full Text] [Related]
2. Thin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts.
Feest ER; Steven Korte F; Tu AY; Dai J; Razumova MV; Murry CE; Regnier M
J Mol Cell Cardiol; 2014 Jul; 72():219-27. PubMed ID: 24690333
[TBL] [Abstract][Full Text] [Related]
3. Calcium binding kinetics of troponin C strongly modulate cooperative activation and tension kinetics in cardiac muscle.
Kreutziger KL; Piroddi N; McMichael JT; Tesi C; Poggesi C; Regnier M
J Mol Cell Cardiol; 2011 Jan; 50(1):165-74. PubMed ID: 21035455
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Ca2+ binding of cardiac troponin reduces sarcomere length dependence of contractile activation independently of strong crossbridges.
Korte FS; Feest ER; Razumova MV; Tu AY; Regnier M
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H863-70. PubMed ID: 22865385
[TBL] [Abstract][Full Text] [Related]
5. Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts.
Powers JD; Kooiker KB; Mason AB; Teitgen AE; Flint GV; Tardiff JC; Schwartz SD; McCulloch AD; Regnier M; Davis J; Moussavi-Harami F
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32931484
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional consequences of cardiac troponin C L57Q and I61Q Ca(2+)-desensitizing variants.
Wang D; McCully ME; Luo Z; McMichael J; Tu AY; Daggett V; Regnier M
Arch Biochem Biophys; 2013 Jul; 535(1):68-75. PubMed ID: 23454346
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional impact of troponin C-mediated Ca
Gonzalez-Martinez D; Johnston JR; Landim-Vieira M; Ma W; Antipova O; Awan O; Irving TC; Bryant Chase P; Pinto JR
J Mol Cell Cardiol; 2018 Oct; 123():26-37. PubMed ID: 30138628
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca
Halas M; Langa P; Warren CM; Goldspink PH; Wolska BM; Solaro RJ
Mol Pharmacol; 2022 May; 101(5):286-299. PubMed ID: 35236770
[TBL] [Abstract][Full Text] [Related]
9. Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?
Dweck D; Hus N; Potter JD
J Biol Chem; 2008 Nov; 283(48):33119-28. PubMed ID: 18820258
[TBL] [Abstract][Full Text] [Related]
10. Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study.
Dewan S; McCabe KJ; Regnier M; McCulloch AD; Lindert S
J Phys Chem B; 2016 Aug; 120(33):8264-75. PubMed ID: 27133568
[TBL] [Abstract][Full Text] [Related]
11. Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C.
Parvatiyar MS; Pinto JR; Liang J; Potter JD
J Biol Chem; 2010 Sep; 285(36):27785-97. PubMed ID: 20566645
[TBL] [Abstract][Full Text] [Related]
12. Sarcomere integrated biosensor detects myofilament-activating ligands in real time during twitch contractions in live cardiac muscle.
Vetter AD; Martin AA; Thompson BR; Thomas DD; Metzger JM
J Mol Cell Cardiol; 2020 Oct; 147():49-61. PubMed ID: 32791214
[TBL] [Abstract][Full Text] [Related]
13. Engineered troponin C constructs correct disease-related cardiac myofilament calcium sensitivity.
Liu B; Lee RS; Biesiadecki BJ; Tikunova SB; Davis JP
J Biol Chem; 2012 Jun; 287(24):20027-36. PubMed ID: 22511780
[TBL] [Abstract][Full Text] [Related]
14. A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.
Parvatiyar MS; Landstrom AP; Figueiredo-Freitas C; Potter JD; Ackerman MJ; Pinto JR
J Biol Chem; 2012 Sep; 287(38):31845-55. PubMed ID: 22815480
[TBL] [Abstract][Full Text] [Related]
15. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
[TBL] [Abstract][Full Text] [Related]
16. Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I.
Zhou Z; Rieck D; Li KL; Ouyang Y; Dong WJ
Arch Biochem Biophys; 2013 Jul; 535(1):56-67. PubMed ID: 23246786
[TBL] [Abstract][Full Text] [Related]
17. Sarcomere length dependent effects on the interaction between cTnC and cTnI in skinned papillary muscle strips.
Li KL; Ghashghaee NB; Solaro RJ; Dong W
Arch Biochem Biophys; 2016 Jul; 601():69-79. PubMed ID: 26944554
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional consequences of the cardiac troponin C L48Q Ca(2+)-sensitizing mutation.
Wang D; Robertson IM; Li MX; McCully ME; Crane ML; Luo Z; Tu AY; Daggett V; Sykes BD; Regnier M
Biochemistry; 2012 Jun; 51(22):4473-87. PubMed ID: 22591429
[TBL] [Abstract][Full Text] [Related]
19. Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C.
Tikunova SB; Thuma J; Davis JP
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569724
[TBL] [Abstract][Full Text] [Related]
20. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
